EligibleTrials

Study of MAR001 in Adults With Elevated Triglycerides and Remnant Cholesterol

Recruiting · NCT07028749 · Interventional (participants receive a specific treatment) · Lead sponsor: Marea Therapeutics

View the official record on ClinicalTrials.gov →
High cholesterol

Interventions studied

MAR001Placebo

What this trial is about

The primary objective of the study is to evaluate the effect of MAR001 compared to placebo on levels of TG in adults with elevated TG and RC.

Who can take part

Age range
18 Years to 75 Years
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Phase 2
Study type
Interventional (participants receive a specific treatment)

Inclusion criteria

Exclusion criteria

Where it is running

55 locations listed across 16 US states.

Read the full protocol, contacts and eligibility on ClinicalTrials.gov →

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.